Corebridge Financial (NYSE: CRBG) and Equitable Holdings (NYSE: EQH) announce $22bn all-stock merger to create $1.5tn retirement and asset management giant
Is Firefly Neuroscience, Inc. building a scalable AI diagnostics platform through U.S. defense healthcare partnerships? (NASDAQ: AIFF)
Enerpac Tool Group (NYSE: EPAC) posts 10-quarter-high product growth as EMEA service slump and $51m buyback reshape its fiscal 2026 outlook
Read More 2 minute read Pharma Industry News Takeda’s NINLARO fails to meet PFS primary endpoint in TOURMALINE-MM2 trial Takeda Pharmaceutical said that the Phase 3 TOURMALINE-MM2 trial in newly diagnosed multiple myeloma patients for NINLARO (ixazomib)… bypharmanewsdailySeptember 11, 2020
